1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GALECTO INC
Galecto Inc
XNAS: DMRA
Download real time
22.59 -0.19 (-0.83%)
41.05% Fall from 52W High
3.3M
XNAS Volume
High volume today

XNAS 18 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for Galecto Inc

The latest disclosure was made by Garrett Winslow in Galecto Inc where a trade of 680 Restricted Stock Units done was reported to US exchanges on July 3, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Garrett Winslow General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jul 2026 680 640 - - Restricted Stock Units
Garrett Winslow General Counsel Sale of securities on an exchange or to another person at price $ 29.98 per share. 03 Jul 2026 245 2,289 - 30.0 7,345 Common Stock
Garrett Winslow General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jul 2026 680 2,534 - - Common Stock
Jennifer Ann Jarrett Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2026 1,500,000 1,500,000 - - Stock Option (right to buy)
Jennifer Ann Jarrett Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2026 500,000 500,000 - 0 Common Stock
Michael Landsittel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2026 37,313 37,313 - - Stock Option (right to buy)
Cameron Turtle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2026 37,313 37,313 - - Stock Option (right to buy)
Garrett Winslow General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2026 250,000 250,000 - - Stock Option (right to buy)
Julianne Bruno Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2026 37,313 37,313 - - Stock Option (right to buy)
Julianne Bruno Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2026 129,000 137,032 - 0 Common Stock
Julianne Bruno Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2026 129 0 - - Series C Preferred Stock
Sherwin Sattarzadeh Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2026 444,209 444,209 - - Stock Option (right to buy)
Sherwin Sattarzadeh Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2026 190,376 190,376 - 0 Common Stock
Becker Hewes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2026 264,629 264,629 - 0 Common Stock
Becker Hewes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2026 528,603 528,603 - - Stock Option (right to buy)
Garrett Winslow General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2026 680 2,109 - - Common Stock
Garrett Winslow General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2026 680 1,320 - - Restricted Stock Units
Garrett Winslow General Counsel Sale of securities on an exchange or to another person at price $ 21.38 per share. 02 Jan 2026 255 1,854 - 21.4 5,452 Common Stock
Lori Firmani Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2026 374 726 - - Restricted Stock Units
Lori Firmani Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2026 374 1,066 - - Common Stock
Lori Firmani Chief Financial Officer Sale of securities on an exchange or to another person at price $ 21.41 per share. 02 Jan 2026 135 931 - 21.4 2,890 Common Stock
Hans T. Schambye Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2026 1,360 5,382 - - Common Stock
Hans T. Schambye Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2026 1,360 2,640 - - Restricted Stock Units
Hans T. Schambye Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 21.38 per share. 02 Jan 2026 700 4,682 - 21.4 14,966 Common Stock
Garrett Winslow General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jul 2025 680 2,000 - - Restricted Stock Units
Garrett Winslow General Counsel Sale of securities on an exchange or to another person at price $ 3.39 per share. 03 Jul 2025 260 1,429 - 3.4 881 Common Stock
Garrett Winslow General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jul 2025 680 1,689 - - Common Stock
Lori Firmani Interim CFO 03 Jul 2025 374 839 - - Common Stock
Lori Firmani Interim CFO 03 Jul 2025 374 1,100 - - Restricted Stock Units
Lori Firmani Interim CFO 03 Jul 2025 147 692 - 3.4 498 Common Stock
Hans T. Schambye Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 3.38 per share. 03 Jul 2025 735 4,022 - 3.4 2,484 Common Stock
Hans T. Schambye Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jul 2025 1,360 4,000 - - Restricted Stock Units
Hans T. Schambye Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jul 2025 1,360 4,757 - - Common Stock
Carl S. Goldfischer Director 18 Jun 2025 1,440 1,440 - - Stock Option (right to buy)
David Shapiro Director 18 Jun 2025 720 720 - - Stock Option (right to buy)
Amit D. Munshi Director 18 Jun 2025 720 720 - - Stock Option (right to buy)
Jayson Dallas Director 18 Jun 2025 720 720 - - Stock Option (right to buy)
Amy B. Wechsler Director 18 Jun 2025 720 720 - - Stock Option (right to buy)
Anne Prener Director 18 Jun 2025 720 720 - - Stock Option (right to buy)
Garrett Winslow General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2025 1,320 1,480 - - Common Stock
Garrett Winslow General Counsel Sale of securities on an exchange or to another person at price $ 5.60 per share. 03 Jan 2025 471 1,009 - 5.6 2,638 Common Stock
Garrett Winslow General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2025 1,320 2,680 - - Restricted Stock Units
Garrett Winslow General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 6,000 6,000 - - Stock Option (right to buy)
Hans T. Schambye Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 16,400 16,400 - - Stock Option (right to buy)
Hans T. Schambye Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2025 2,640 4,738 - - Common Stock
Hans T. Schambye Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 5.60 per share. 03 Jan 2025 1,341 3,397 - 5.6 7,510 Common Stock
Hans T. Schambye Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2025 2,640 5,360 - - Restricted Stock Units
Matthew Kronmiller EVP Strategy and CBO 03 Jan 2025 6,000 6,000 - - Stock Option (right to buy)
Lori Firmani Interim CFO 03 Jan 2025 5,000 5,000 - - Stock Option (right to buy)
Lori Firmani Interim CFO 03 Jan 2025 726 1,474 - - Restricted Stock Units
Lori Firmani Interim CFO 03 Jan 2025 261 465 - 5.6 1,469 Common Stock
Lori Firmani Interim CFO 03 Jan 2025 726 726 - - Common Stock
Schambye Hans T. Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Oct 2024 44,100 44,100 - - Stock Option (right to buy)
Kronmiller Matthew EVP Strategy and CBO 09 Oct 2024 8,600 8,600 - - Stock Option (right to buy)
Winslow Garrett General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Oct 2024 15,600 15,600 - - Stock Option (right to buy)
David Shapiro Director 20 Jun 2024 18,000 18,000 - - Stock Option (right to buy)
Anne Prener Director 20 Jun 2024 18,000 18,000 - - Stock Option (right to buy)
Carl S. Goldfischer Director 20 Jun 2024 36,000 36,000 - - Stock Option (right to buy)
Amit D. Munshi Director 20 Jun 2024 18,000 18,000 - - Stock Option (right to buy)
Jayson Dallas Director 20 Jun 2024 18,000 18,000 - - Stock Option (right to buy)
Garrett Winslow General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2024 100,000 100,000 - - Restricted Stock Units
T. Schambye Hans Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2024 200,000 200,000 - - Restricted Stock Units
Freve Jonathan Chief Financial Officer 03 Jan 2024 100,000 100,000 - - Restricted Stock Units
Carl S. Goldfischer Director 14 Jun 2023 36,000 36,000 - - Stock Option (right to buy)
David Shapiro Director 14 Jun 2023 18,000 18,000 - - Stock Option (right to buy)
Amit D. Munshi Director 14 Jun 2023 18,000 18,000 - - Stock Option (right to buy)
Chau Q. Khuong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 18,000 18,000 - - Stock Option (right to buy)
Jayson Dallas Director 14 Jun 2023 18,000 18,000 - - Stock Option (right to buy)
Anne Prener Director 14 Jun 2023 18,000 18,000 - - Stock Option (right to buy)
Jonathan Freve Chief Financial Officer 04 Jan 2023 115,000 115,000 - - Stock Option (right to buy)
Bertil Lindmark Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2023 115,000 115,000 - - Stock Option (right to buy)
Garrett Winslow General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2023 80,000 80,000 - - Stock Option (right to buy)
Hans T. Schambye Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2023 300,000 300,000 - - Stock Option (right to buy)
Anders Pedersen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2023 115,000 115,000 - - Stock Option (right to buy)
Stephanie Oestreich Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2023 80,000 80,000 - - Stock Option (right to buy)
Carl S. Goldfischer Director 14 Jun 2022 36,000 36,000 - - Stock Option (right to buy)
David Shapiro Director 14 Jun 2022 18,000 18,000 - - Stock Option (right to buy)
Amit D. Munshi Director 14 Jun 2022 18,000 18,000 - - Stock Option (right to buy)
Chau Q. Khuong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 18,000 18,000 - - /s/ Jonathan Freve, attorney-in-fact
Jayson Dallas Director 14 Jun 2022 18,000 18,000 - - Stock Option (right to buy)
Anne Prener Director 14 Jun 2022 18,000 18,000 - - Stock Option (right to buy)
Bertil Lindmark Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 2.16 per share. 22 Mar 2022 14,604 16,604 - 2.2 31,545 Common Stock
Hans T. Schambye Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.15 per share. 22 Mar 2022 5,000 52,428 - 2.2 10,750 Common Stock
Stephanie Oestreich Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 140,000 140,000 - - Stock Option (right to buy)
Jonathan Freve Chief Financial Officer 04 Jan 2022 118,750 118,750 - - Stock Option (right to buy)
Bertil Lindmark Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 118,750 118,750 - - Stock Option (right to buy)
Hans T. Schambye Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 287,500 287,500 - - Stock Option (right to buy)
Anders Pedersen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 118,750 118,750 - - Stock Option (right to buy)
Jonathan Freve Chief Financial Officer 03 Dec 2021 4,000 12,000 - 2.5 9,960 Common Stock
Carl S. Goldfischer Director 17 Nov 2021 18,000 18,000 - - Stock Option (right to buy)
Chau Q. Khuong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Nov 2021 9,000 9,000 - - Stock Option (right to buy)
Hans T. Schambye Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 3.50 per share. 09 Nov 2021 4,500 47,428 - 3.5 15,750 Common Stock
Jonathan Freve Chief Financial Officer 08 Nov 2021 3,000 8,000 - 3.4 10,200 Common Stock
Jonathan Freve Chief Financial Officer 18 Aug 2021 3,000 5,000 - 3.9 11,760 Common Stock
Bertil Lindmark Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 5.26 per share. 28 Jun 2021 2,000 2,000 - 5.3 10,520 Common Stock
Hans T. Schambye Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 5.11 per share. 24 Jun 2021 3,000 42,928 - 5.1 15,330 Common Stock
Jonathan Freve Chief Financial Officer 23 Jun 2021 2,000 2,000 - 4.7 9,480 Common Stock
Carl S. Goldfischer Director 26 May 2021 18,000 18,000 - - Stock Option (right to buy)
Chau Q. Khuong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2021 18,000 18,000 - - Stock Option (right to buy)
Jayson Dallas Director 26 May 2021 18,000 18,000 - - Stock Option (right to buy)
Anne Prener Director 26 May 2021 18,000 18,000 - - Stock Option (right to buy)
Anne Prener Director 08 Jan 2021 6,000 6,000 - - Stock Option (right to buy)
Anne Prener Director 08 Jan 2021 18,000 18,000 - - Stock Option (right to buy)
Jonathan Freve Chief Financial Officer 05 Jan 2021 95,000 95,000 - - Stock Option (right to buy)
Bertil Lindmark Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 95,000 95,000 - - Stock Option (right to buy)
Hans T. Schambye Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 230,000 230,000 - - Stock Option (right to buy)
Anders Pedersen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 100,000 100,000 - - Stock Option (right to buy)
Carl S. Goldfischer Director 02 Nov 2020 9,587 9,587 - - Common Stock
Carl S. Goldfischer Director 02 Nov 2020 3,688 0 - - Series D Preferred Stock
Carl S. Goldfischer Director 02 Nov 2020 7,475 0 - - Series C-3 Preferred Stock
Carl S. Goldfischer Director 02 Nov 2020 392,367 0 - - Series C-3 Preferred Stock
Carl S. Goldfischer Director 02 Nov 2020 3,688 3,688 - - Series D Preferred Stock
Carl S. Goldfischer Director 02 Nov 2020 19,432 19,432 - - Common Stock
Carl S. Goldfischer Director 02 Nov 2020 1,020,036 1,020,036 - - Common Stock
Amit D. Munshi Director 02 Nov 2020 109,187 109,187 - - Stock Option (right to buy)
Amit D. Munshi Director 02 Nov 2020 4,793 4,793 - - Common Stock
Amit D. Munshi Director 02 Nov 2020 1,844 0 - - Series D Preferred Stock
Amit D. Munshi Director 02 Nov 2020 1,844 1,844 - - Series D Preferred Stock
Chau Q. Khuong Director, Ten Percent Owner 02 Nov 2020 272,533 0 - - Series C-4 Preferred Stock
Chau Q. Khuong Director, Ten Percent Owner 02 Nov 2020 116,800 0 - - Series C-2 Preferred Stock
Chau Q. Khuong Director, Ten Percent Owner 02 Nov 2020 291,999 0 - - Series C-2 Preferred Stock
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2020 73,773 73,773 - - Series D Preferred Stock
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2020 59,350 59,350 - - Series D Preferred Stock
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2020 148,395 148,395 - - Series D Preferred Stock
Chau Q. Khuong Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 15.00 per share. 02 Nov 2020 209,500 1,031,811 - 15 3,142,500 Common Shares
Chau Q. Khuong Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 15.00 per share. 02 Nov 2020 523,833 2,579,657 - 15 7,857,495 Common Shares
Chau Q. Khuong Director, Ten Percent Owner 02 Nov 2020 191,787 191,787 - - Common Shares
Chau Q. Khuong Director, Ten Percent Owner 02 Nov 2020 822,311 822,311 - - Common Shares
Chau Q. Khuong Director, Ten Percent Owner 02 Nov 2020 2,055,824 2,055,824 - - Common Shares
Chau Q. Khuong Director, Ten Percent Owner 02 Nov 2020 73,773 0 - - Series D Preferred Stock
Chau Q. Khuong Director, Ten Percent Owner 02 Nov 2020 148,395 0 - - Series D Preferred Stock
Chau Q. Khuong Director, Ten Percent Owner 02 Nov 2020 59,350 0 - - Series D Preferred Stock
Chau Q. Khuong Director, Ten Percent Owner 02 Nov 2020 31,147 0 - - Series C-5 Preferred Stock
Chau Q. Khuong Director, Ten Percent Owner 02 Nov 2020 77,866 0 - - Series C-5 Preferred Stock
Chau Q. Khuong Director, Ten Percent Owner 02 Nov 2020 109,013 0 - - Series C-4 Preferred Stock
Hans T. Schambye Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2020 519,940 519,940 - - Stock Option (right to buy)
Hans T. Schambye Director, Chief Executive Officer 02 Nov 2020 13,931 39,928 - - Common Stock
Hans T. Schambye Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2020 207,976 207,976 - - Stock Option (right to buy)
Hans T. Schambye Director, Chief Executive Officer 02 Nov 2020 5,359 0 - - Series C-1 Preferred Stock
Anders Pedersen Chief Operating Officer 02 Nov 2020 3,746 3,746 - - Common Stock
Anders Pedersen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2020 142,983 142,983 - - Stock Option (right to buy)
Anders Pedersen Chief Operating Officer 02 Nov 2020 1,441 0 - - Series C-1 Preferred Stock
Anders Pedersen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2020 77,991 77,991 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters